The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
PropertyValue
has minor subject area list Abciximab; Cell Communication; Humans; In Vitro Techniques; Leukocyte Count; Neutrophil Activation; Platelet Activation; Platelet Count
Search Criteria
  • Neutrophil Activation